Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain (Q39321891)
scientific article
Language:
(P31) (Q13442814)
(P304) 271-281
(P407) (Q1860)
(P433) 3
(P478) 9
(P577) Tuesday, April 1, 2008
(P921) (Q6934595)
(Q1088113)
(Q81225)
(P1433) (Q15746562)
(P1476) "Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain" (language: en)
(P2093) Mark S Wallace
Peter S Kosek
Peter Staats
Robert Fisher
David M Schultz
Michael Leong
(P2860) (Q35785670)
(Q39386029)
(Q46080589)
(Q51982361)
(Q46065077)
(Q48499005)
(Q33880857)
(Q42723050)
(Q44098015)
(Q43645608)
(Q39419945)
(Q39387910)
(Q34326398)
(Q39445852)
other details
description scientific article

External Links